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Summary
Background: Although sleep is conserved throughout evolu-
tion, the molecular basis of its control is still largely a mystery.
We previously showed that the quiver/sleepless (qvr/sss) gene
encodes a membrane-tethered protein that is required for
normal sleep in Drosophila. SLEEPLESS (SSS) protein func-
tions, at least in part, by upregulating the levels and open prob-
ability of Shaker (Sh) potassium channels to suppress
neuronal excitability and enable sleep. Consistent with this
proposed mechanism, loss-of-function mutations in Sh phe-
nocopy qvr/sss-null mutants. However, sleep is more geneti-
cally modifiable in Sh than in qvr/sss mutants, suggesting
that SSSmay regulate additional molecules to influence sleep.
Results: Here we show that SSS also antagonizes nicotinic
acetylcholine receptors (nAChRs) to reduce synaptic trans-
mission and promote sleep. Mimicking this antagonism with
the nAChR inhibitor mecamylamine or by RNAi knockdown
of specific nAChR subunits is sufficient to restore sleep to
qvr/sss mutants. Regulation of nAChR activity by SSS occurs
posttranscriptionally, since the levels of nAChR mRNAs are
unchanged in qvr/sss mutants. Regulation of nAChR activity
by SSSmay in fact be direct, since SSS forms a stable complex
with and antagonizes nAChR function in transfected cells.
Intriguingly, lynx1, a mammalian homolog of SSS, can partially
restore normal sleep to qvr/sss mutants, and lynx1 can form
stable complexes with Shaker-type channels and nAChRs.
Conclusions: Together, our data point to an evolutionarily
conserved, bifunctional role for SSS and its homologs in con-
trolling excitability and synaptic transmission in fundamental
processes of the nervous system such as sleep.
Introduction
Sleep is an essential process that is highly conserved across
evolution, yet its functions and underlyingmechanisms of con-
trol are poorly understood. One of the most conserved fea-
tures of sleep is its association with large-scale changes in
brain activity relative to thewaking state, suggesting thatmod-
ulation of neuronal activity may be central to the regulation of
sleep. In support of this hypothesis, homologous genes in
mammals and flies encoding ion channels and ionotropic re-
ceptors have been shown to be necessary for normal sleep
[1–4]. The requirement for potassium (K) channels in the
Shaker (Sh) family is particularly notable. In both mammals*Correspondence: wjoiner@ucsd.eduand flies, loss-of-function mutations in Sh or its orthologs
cause reduced sleep [2, 4]. Although little is known about
whether modulators of Sh-type channels might control sleep
in mammals, loss-of-function mutations in either of two genes
that upregulate Sh, hyperkinetic (Hk) and quiver/sleepless
(qvr/sss), result in reduced sleep in flies [5–7]. Unlike Hk, which
is a cytosolic protein, SSS is anchored by glycosylphosphati-
dylinositol (GPI) to the outer leaflet of the plasma membrane,
where it may associate with the extracellular surfaces of other
membrane proteins. Evidence suggests that one such protein
is Sh itself. For example, SSS and Sh are expressed in many of
the same regions of the fly brain, SSS can form a stable
complex with and upregulate levels of Sh protein, and SSS
can increase the activation kinetics and decrease C-type inac-
tivation kinetics of Sh channels in excised patches of trans-
fected cells [6–8].
However, differences between the sleep phenotypes of Sh
and qvr/sss mutants suggest that the two genes may not act
in exactly the same signaling pathways. For example, over
several generations, selection pressure appears to favor the
accumulation of genetic modifiers in populations of Sh mu-
tants to compensate for loss of sleep [4]. In contrast, loss of
sleep in qvr/sss-null mutants is not lost over the same time
span, if at all (unpublished data), signifying that the qvr/sss
phenotype cannot be easily overcome by other naturally
occurring alleles in the genome. Furthermore, although Shmu-
tants exhibit homeostatic recovery sleep after periods of sleep
deprivation [4], this process is impaired in qvr/sssmutants [6].
Collectively, these differences suggest that SSS may have
other downstream effectors that, in combination with Sh,
control sleep.
Clues about the identities of such effectors may be gleaned
from the predicted structure of SSS. Modeling of the tertiary
structure reveals that SSS is a member of a large family of pro-
teins, including snake a-neurotoxins, which possess a ‘‘three-
finger’’ fold that has also been referred to as the ly6 domain [7].
Intriguingly, many of the targets of a-neurotoxins have been
identified as ion channels or acetylcholine signaling pathways.
For example, FS-2 blocks voltage-gated Ca channels [9], fas-
ciculin-I blocks acetylcholinesterase [10], MT2 acts onmusca-
rinic acetylcholine receptors [11], and a-bungarotoxin inhibits
nicotinic acetylcholine receptors (nAChRs) [12]. Although ly6-
domain-encoding homologs of qvr/sss have also been identi-
fied in the genomes of nonvenomous animals [13, 14], in most
cases the endogenous binding partners of the corresponding
proteins have not been identified.
In mammals, however, evidence strongly suggests that two
of these proteins, lynx1 and lynx2, are endogenous antago-
nists of nAChRs. For example, lynx1 and lynx2 can complex
with and accelerate the desensitization rates of a4b2 nAChRs
[15, 16]. Consistent with these effects, lynx1-knockout mice
have extended critical periods for ocular dominance plasticity
that requires nAChR activity [17], and lynx2-knockout mice
have increased nicotine-evoked excitatory postsynaptic po-
tentials in prefrontal cortical pyramidal neurons [18].
As a result of such studies, we hypothesized that the ly6-
domain-containing protein SSS may also antagonize nAChRs
to reduce synaptic transmission. Here we present evidence
Figure 1. sss Neurons Promote Waking and Are Sensitive to Pharmacological Inhibition of nAChRs and K channels
(A) sss neurons are sufficient for waking. sss-Gal4>UAS-TRPA1, UAS-TRPA1>+ and sss-Gal4>+ animals were heat pulsed to 27C from ZT18–ZT24 from a
baseline temperature of 22C. Change in sleepwas calculated as sleep during the heat pulse minus sleep over the equivalent time period 24 hr before. n > 13
animals for each group.
(legend continued on next page)
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receptor inhibition is required for normal sleep in Drosophila.
Specifically, we show that pharmacological or genetic reduc-
tion of nAChR signaling restores sleep to qvr/sss mutants.
We also show that SSS regulates nAChRs posttranscription-
ally, most likely by direct inhibition, since SSS coimmunopre-
cipitates with the fly nAChR Da3 and inhibits nAChR activity
in transfected cells. Finally, we show that the mammalian
SSS homolog lynx1 restores sleep to qvr/sss mutants and
coimmunoprecipitates with a murine homolog of Sh, Kv1.2.
Collectively, our data suggest the existence of an evolution-
arily conserved, dual role for SSS-like molecules in reducing
excitability and synaptic transmission to control essential ner-
vous system functions like sleep.
Results
SSS-Expressing Neurons Are Required for Waking
We previously demonstrated that loss-of-function mutations
in qvr/sss or Sh lead to increased miniature excitatory post-
synaptic potential frequency and reduced Sh current in indi-
vidual muscle fibers at the fly neuromuscular junction (NMJ).
We thus concluded that loss of SSS or Sh leads to increased
excitability. Since this effect is also accompanied by increased
waking, we hypothesized that loss of qvr/sss or Sh leads to
increased activity of wake-promoting neurons in the central
brain. Loss of sleep inqvr/sss andShmutants cannot be attrib-
uted to seizure activity associated with hyperexcitability since
such an effect would reduce locomotor activity, leading to an
apparent increase in sleep, rather than the decrease actually
observed for these animals. Loss of sleep in qvr/sss and Sh
mutants also does not appear to be caused by hyperlocomo-
tion associated with hyperexcitability since waking activity is
unchanged in qvr/sss mutants [6]. To determine the role of
qvr/sss-expressing neurons in control of the sleep/wake cycle
more directly, we used the Gal4/UAS system [19] to express
temperature-sensitive TRPA1 channels [20] in neurons that
normally express qvr/sss [7]. By activating these neurons
with a temperature pulse of 29C for 6 hr from zeitgeber time
(ZT)18–ZT24, sss-Gal4/UAS-TRPA1 animals were deprived of
sleep relative to pulsed controls (Figure 1A and Figure S1A
available online). Thus, activation of qvr/sss-expressing neu-
rons appears to be sufficient for waking.
In addition, we expressed temperature-sensitive shibire
(shits) in qvr/sss neurons under Gal4/UAS control. shits en-
codes a dominant mutant version of dynamin ATPase that
blocks endocytosis and thus exocytosis at restrictive temper-
atures [21]. By raising the temperature of sss-Gal4/UAS-shits
animals to 28C for 6 hr from ZT0–ZT6, we found that sleep
significantly increased in experimental animals compared to
controls that lacked sss-Gal4 or shits expression (Figures 1B(B) sss neurons are necessary for waking. sss-Gal4>UAS-shits, UAS-shits>+ and
temperature of 22C. Change in sleep was calculated as in (A), but over 12 hr (i
animals for each group.
(C) The nAChR antagonist mecamylamine (MCA) dose dependently restores sl
animals (w1118, the genetic background of sssP1 and Shmns mutants). n = 19–4
(D) Twenty-four hour sleep profiles of WT control (top), sssP1 (middle), and Sh
each plot.
(E) The potassium channel antagonist 4-aminopyridine (4-AP) reduces sleep in
animals for each group.
(F) Twenty-four hour sleep profiles of WT control (top), sssP1/sssP2 (middle), and
each plot.
*p < 0.01 and ***p < 0.001 by unpaired t test (A and B) or one-way ANOVA (C and
See also Figures S1–S3.and S1B). This change is indeed sleep and not sickness or
paralysis since experimental animals were able to right them-
selves within 10 s of being inverted during the temperature
pulse (28/31, sss-Gal4>UAS-shits; 32/32, sss-Gal4/+, 32/32,
UAS-shits/+). Thus, activation of qvr/sss-expressing neurons
also appears to be required for waking.
Pharmacological Antagonism of nAChR and Sh Activities
Influences Sleep
We previously demonstrated that a reduction in either SSS or
Sh causes a reciprocal reduction in the other protein [6, 7]. This
observation is consistent with the idea that the two proteins
can form a complex and mutually stabilize each other. These
results led us to hypothesize that restoring the expression of
Sh in qvr/sssmutants or vice versa using the Gal4/UAS system
might rescue the severe sleep defects observed in both
groups of animals. However, expression of UAS-Sh in sssP1
mutants or UAS-sss in Shmns mutants under the control of
sss-Gal4 was not sufficient to restore sleep to normal levels
(Figure S1C), suggesting that additional factors might be
required.
Interestingly, SSS is homologous to the endogenous nAChR
antagonists lynx1 and lynx2, aswell as to snake a-neurotoxins,
some ofwhich also affect acetylcholine signaling. Thus, we hy-
pothesized that SSS might normally reduce nAChR activity in
wake-promoting neurons to enable animals to sleep. Accord-
ing to this hypothesis, nAChR activity should be elevated in
qvr/sss loss-of-function mutants, and perhaps in Sh mutants
as well, since Sh upregulates SSS. To test this hypothesis,
we fed WT, sssP1, and Shmns flies increasing concentrations
of the noncompetitive nAChR antagonist mecamylamine
(MCA) andmeasured sleep 24–48 hr later. We found that treat-
ment of WT animals with drug caused only a small increase in
sleep. In contrast, treatment of both sssP1 and Shmns mutants
with MCA caused a dose-dependent restoration of sleep (Fig-
ures 1C and 1D). We interpret these changes as true sleep
rather than sickness or paralysis because the behavioral state
was acutely reversible with brief mechanical agitation, and
waking activity with drug treatment was as high as controls
(Figures S2A and S2B). These findings strongly suggest that
the ability of SSS and Sh to promote sleep under normal con-
ditions is mediated in part by a suppression of nAChR activity
and that loss of this suppression leads to reduced sleep in qvr/
sss and Sh mutants. This mechanism seems to be at least
somewhat selective for qvr/sss and Sh mutants since meca-
mylamine was not able to increase sleep in Clkjrkmutants (Fig-
ure S3), which have been reported to have low sleep [22–24].
Althoughwe previously reported that SSS enhances both Sh
protein levels and gating kinetics, at that time we did not
demonstrate a direct role for Sh in mediating the low-sleeping
phenotype of qvr/sss mutants. To examine this relationship,sss-Gal4>+ animals were heat pulsed to 28C from ZT0–ZT6 from a baseline
nstead of 6) due to a heat-dependent shift in timing of daytime sleep. n > 15
eep to qvr/sss and Shmutants but has little effect on wild-type (WT) control
0 animals for each group.
mns (bottom) animals used to collect the data in (C). n = 19–40 animals for
WT controls but has no effect on sssP1/sssP2 and Shmns mutants. n = 10–69
Shmns (bottom) animals used to collect the data in (E). n = 10–69 animals for
E) with Bonferroni post test. ns, not significant. Error bars indicate the SEM.
Figure 2. RNAi Knockdown of nAChR Subunits Restores Sleep to qvr/sss
Mutants
(A) Sleep in sss-Gal4/+;UAS-RNAi/UAS-dicer animals compared to UAS-
RNAi/+ controls (all in a sssP1 background). The low-sleeping phenotype
of sssP1 mutants is rescued by knockdown of Da3 and to a lesser extent
Db3. n > 26 for each group.
(B) Twenty-four hour sleep profiles of sssP1 alone or sssP1 animals in which
Da3 has been knocked down in sss neurons.
(C) Overexpression ofDa3 in sss neurons reduces total daily sleep. n > 15 for
each group.
***p < 0.001 by one-way ANOVA with Bonferroni post test. Error bars indi-
cate the SEM. See also Figures S2 and S4.
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activity in WT animals could reduce sleep, as observed in
sssP1 and Shmns mutants. To accomplish this task, we fed
animals the voltage-gated potassium channel blocker 4-ami-
nopyridine (4-AP). 4-AP treatment was able to dose-depen-
dently reduce sleep in a WT background to levels similar to
those observed in Shmns mutants, but did not affect waking
activity (Figures 1E, 1F, and S2C). 4-AP appeared to act selec-
tively on Sh rather than on other ion channels to reduce sleep
since therewas no effect of the drug onShmnsmutants (Figures
1Eand1F). Tellingly, in transheterozygous sssP1/sssP2mutants
in which sleep was reduced to levels equivalent to those
observed in Shmns mutants, 4-AP also had no acute effect.
These results suggest that the reduced sleep in qvr/sss mu-
tants is at least partially mediated by a reduction in Sh activity,
which in turn leads to increased neuronal excitability in
arousal-promoting neurons, as previously hypothesized [6, 7].
qvr/sss Genetically Interacts with nAChR Subunits to
Control Sleep
After determining that acute antagonism of nAChR activity
could restore sleep to sssP1 mutants, we asked which nAChR
subunits might be aberrantly upregulated in the absence of
SSS. To address this question, we first determined whichnAChR subunits are expressed in the adult fly brain. In
mammals, nAChRs are homopentamers of alpha subunits or
heteropentameters of alpha and beta subunits. In the fly
genome, there are seven genes encoding alpha subunits
(Da1–Da7) and three genes encoding beta subunits (Db1–
Db3). The combinations of receptor subunits that can form
functional channels in flies are unknown, largely because it
has been difficult to measure activity of cloned fly nAChRs in
heterologous expression systems [25]. Using quantitative
PCR (qPCR) to measure the levels of nAChR transcripts, we
found that all but one subunit is enriched in the adult fly brain
relative to the body (Figure S4A).
To determine which of these subunits might be responsible
for the increased waking time of qvr/sssmutants, we reduced
expression of each alpha or beta subunit in sss-expressing
neurons by RNAi knockdown. Consistent with our hypothesis
that nAChR activity is upregulated in qvr/sss mutants, knock-
down of Da3 in particular, and to a lesser extent Db3, partly
restored sleep to sssP1 mutants (Figures 2A and 2B) without
affecting waking activity (Figure S2D), but had no effect on
sleep in control animals with normal levels of qvr/sss expres-
sion (Figure S4B). qPCR analysis of Da3 transcripts from
heads of panneuronal RNAi knockdown flies confirms an
w65% reduction in Da3 expression levels (Figure S4C).
These results suggest that excessive nAChR activity may
be at least partly responsible for the increased waking time
of sssP1 mutants. These results also indicate that nAChR
activity does not normally need to be reduced by withdrawal
of endogenous cholinergic signaling to allow WT animals to
sleep.
To determine whether upregulation of nAChR activity in qvr/
sss-expressing neurons could reduce sleep, we coupled sss-
Gal4 to a P element (d08339) inserted w40 bp upstream of
the predicted transcriptional start site of the Da3 gene. Since
this P element carries UAS sequences pointing in both direc-
tions along the X chromosome, animals bearing it in combina-
tion with sss-Gal4 should express elevated levels of Da3
transcript. When we tested these animals, we found that
they expressed very high levels of Da3 mRNA and slept less
than controls (Figures S4D and 2C). Thus, upregulation of
Da3 nAChRs in qvr/sss-expressing neurons is sufficient to
account for at least part of the low-sleeping phenotype of
sssP1 mutants.
nAChRs Are Posttranscriptionally Regulated by SSS and
Colocalize with SSS and Sh in the Mushroom Bodies
To determine whether SSS can indirectly regulate nAChRs by
transcriptional feedback, we performed qPCR on Da3 and
Db3, two of the nAChR subunits that genetically interacted
with qvr/sss (Figures 2A and 2B). Just as we previously
showed for regulation of Sh transcript [7], levels of fly brain
nAChR transcripts are unchanged in sssP1 mutants. We also
found that fly brain nAChR transcripts are similarly unchanged
inShmnsmutants (Figure 3A). Collectively, these data support a
posttranscriptional role for regulation of nAChR activity by
SSS, although we cannot exclude the possibility that upregu-
lation of nAChR transcript in qvr/sssmutants occurs in a small
subset of the neurons in our whole-brain preparations and is
therefore undetectable in our assays.
If, however, SSS is acting directly on both K channels and
nAChRs to suppress neuronal activity and promote sleep,
then SSS and both effector proteins should be expressed
in the same set of neurons. To determine whether this is
indeed the case, we labeled qvr/sss-expressing neurons
Figure 3. Da3 and Db3 Are Not Transcriptionally
Regulated by SSS or Sh but Coexpress with
Them in the Mushroom Bodies
(A) Quantitative PCR analyses of Da3 and Db3
transcripts show no dependence on qvr/sss or
Sh for normal expression. n = 3 for each group.
ns, not significant by one-way ANOVA with Bon-
ferroni post test. Error bars indicate the SEM.
(B) Coexpression of sss, Sh, and Da3 in themush-
room bodies. Representative immunostaining
(n = 8) of tdTomato expressed under the control
of sss-Gal4 (top), native Sh protein (middle),
and native Da3 protein (bottom). Scale bars
represent 25 mm.
(C) MB-Gal80 suppresses rescue of sleep by sss-
Gal4>UAS-sss in sssP1 mutants. n > 30 for all
groups. ***p < 0.001 by one-way ANOVA with
Bonferroni post test. Error bars indicate the SEM.
See also Figure S5.
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In the same brains, we also stained for the presence of Sh
and Da3 using established antibodies for each molecule
[7, 26]. We found overlapping expression of all three mole-
cules in the mushroom bodies (MBs) (Figure 3B), which we
and others previously showed to be important sleep-regula-
tory loci [27, 28]. Our cell labeling was likely to be specific
for the intended antigens since Sh labeling disappeared in
Sh mutants [7], Da3 labeling was significantly reduced
when antibody was preincubated with lysate from COS cells
transfected with Da3 cDNA (Figures S5A–S5C), and Da3
labeling increased in brains of animals in which sss-Gal4
was combined with UAS-Da3 (i.e., P element d08339) (Fig-
ure S5D). Thus, the sleep-regulating proteins SSS, Sh, and
Da3 are expressed together in a known sleep-regulating
locus in the fly brain.
To determine whether the MBs might contribute to sleep
regulation by qvr/sss, we first coupled the sss-Gal4 driver to
UAS-sss in a sssP1 mutant background. As we previously
demonstrated [7], we found that the qvr/sss transgene was
capable of fully rescuing the loss of sleep in sssP1 mutants.
However, when we blocked expression of the qvr/sss trans-
gene with MB-Gal80, a repressor of Gal4 activity that
expresses in the MBs, restoration of sleep to otherwise genet-
ically identical animals was reduced (Figure 3C). These data
suggest that qvr/sss utilizes the MBs to regulate sleep, though
they do not exclude the possibility that other brain regionsmay
also be involved.
SSS Forms Stable Complexes with Both Sh and Da3
Our findings that SSS upregulates Sh and antagonizes nAChR
activity in vivo suggest that SSS might mediate these effects
directly. We previously demonstrated that SSS can form a
complex with Sh channels in Xenopus oocytes, which express
K currents very robustly after injection of Sh cRNA. To deter-
mine whether SSS can form complexes with Sh channels
and with nAChRs in transfected cells, we first added a MYC
epitope near the C terminus of SSS, just before the attachment
site of glycosylphosphatidylinositol. We also fused GFP and
hemagglutinin (HA) epitopes to the N and C termini of Sh and
Da3, respectively. These constructs were expressed in HEK-
tsa cells, and complexes were immunoprecipitated with
antibodies against either GFP (i.e., Sh) or HA (i.e., Da3). Subse-
quent western blot analyses revealed that SSS can be coim-
munoprecipitated with Sh (Figure 4A) or Da3 (Figure 4B), but
not in the absence of the channel or receptor (Figures 4Aand 4B). These results demonstrate that SSS can form stable
complexes with both Sh and Da3.
SSS Reduces nAChR Activity
Regulation of Sh kinetics by SSS has previously been demon-
strated in multiple expression systems [7, 8]. To determine
whether complexes formed by SSS and nAChRs also result
in altered receptor activity, we examined the contribution of
SSS to nAChR function in transfected HEK-tsa cells. For these
experiments, we used nAChRs frommice because fly nAChRs
have been recalcitrant to functional expression on their own. In
the absence of clear murine orthologs of fly nAChRs, we chose
a4/b2 for our assay because these receptors express well in
heterologous expression systems. In our assay, we measured
agonist-dependent influx of Ca2+ through receptors using the
ratiometric fluorescence resonance energy transfer (FRET)-
able cytosolic Ca2+ reporter TN-XXL [29]. In the presence of
a4/b2 and TN-XXL, the nicotinic agonist epibatidine elicited
an increase in FRET ratio that was well fit by a sigmoidal con-
centration-response curve with a half-maximal effective con-
centration (EC50) similar to previous reports [29]. In cells in
which the qvr/sss cDNA was included in the transfection
mixture, however, the maximal nAChR response was reduced
by 75% (Figures 4C and 4D). Thus, in transfected cells, SSS
suppresses nAChR function, just as in vivo. Taken together
with our data showing that SSS and fly nAChRs can form a
stable complex, these findings suggest that the functional
suppression of nAChR activity by SSS is direct.
The Molecular Functions of SSS Homologs Are Conserved
across Evolution
SSS structurally resembles both snake a-neurotoxins such as
a-bungarotoxin, which blocks nAChRs, and other ly6-domain-
containing proteins such as the endogenous mammalian
nAChR antagonists lynx1 and lynx2. While SSS and lynx1
share only 18% amino acid identity, they both contain a series
of conserved cysteines that are thought to form disulfide
bonds that maintain the characteristic ‘‘three-finger’’ tertiary
structure of the ly6 domain [7]. Thus, it is possible that the
tertiary structures of SSS and lynx1 are similar enough that
the two proteins could function interchangeably.
To test this hypothesis, we first performed coimmunopreci-
pitation experiments with MYC-tagged lynx1 and HA-tagged
Da3 in transiently transfected HEK-tsa cells. Lynx1 is known
to associate with mammalian nAChRs, and we found that
like SSS, it could also form stable complexes with Da3
Figure 4. SSS Forms Complexes with nAChRs and Inhibits Their Activity
(A and B) Representative immunoprecipitations of (A) GFP-tagged Sh or (B)
HA-tagged Da3 from transiently transfected Cos-7 cells. Cotransfected
Myc-tagged SSS coimmunoprecipitates with Sh and Da3 (lane 3, both
blots), but not in the absence of Sh (A, lane 1) and Da3 (B, lane 3). IP, immu-
noprecipitations; WB, western blots.
(C) Concentration-response curves depicting a4b2 nAChR activity by the
agonist epibatidine in the absence (solid line) and presence of SSS (dashed
line). nAChR activity was determined by baseline-subtracted (i.e., agonist
minus no agonist) FRET between the CFP and YFP domains of the geneti-
cally encoded Ca2+ sensor TN-XXL in HEK-tsa cells transiently transfected
with mouse a4 and b2 nAChR subunits, TN-XXL, and either sss cDNA or
empty vector (n = 4 for each point).
(D) SSS suppresses maximal a4b2 nAChR activity. Quantitation of maximal
values measured in (C). All numbers were normalized to values obtained for
activated a4b2 nAChRs in the absence of SSS (n = 4). **p < 0.01 by paired
t test.
Error bars indicate the SEM in (C) and (D).
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was also able to associate with voltage-gated K channels.
We fusedGFP to the N terminus of Sh aswell as itsmammalian
homolog, Kv1.2, and cotransfected cells with each construct
along with the MYC-tagged lynx1 cDNA. In both cases we
found that lynx1 could be coimmunoprecipitated with the
K channel (Figure 5B). The formation of these complexes
cannot be attributed to a tendency for lynx1 to associate
with other proteins nonspecifically since lynx1 could not be
coimmunoprecipitatedwith themembrane proteinGRID2 (Fig-
ure 5B). These results suggest that the targeting of voltage-
gated K channels and nAChRs by ly6 proteins is conserved
across evolution.
On the basis of this conservation of molecular function, we
testedwhether lynx1 could replace SSS and allow flies to sleep
normally. We generated UAS-lynx1 transgenic flies and ex-
pressed lynx1 under the control of sss-Gal4. Remarkably, we
found that lynx1 can restore sleep to sssP1 mutants without
altering waking activity (Figures 5C and S2E), demonstrating
that lynx1 can function sufficiently like SSS to substitute for
the latter in vivo.Discussion
We previously demonstrated that SSS couples Sh levels and
gating kinetics to reduced membrane excitability to allow
sleep in Drosophila. Here we show that SSS interacts with
and antagonizes nAChRs to promote sleep as well and that
the activity of sss-expressing neurons is both necessary and
sufficient for this process in Drosophila. The molecular bifunc-
tionality of SSS is unexpected since K channels and nAChRs
are functionally and structurally unrelated. For example, Sh-
type channels are gated by voltage, have six transmembrane
domains and multimerize to form functional tetramers. In
contrast, nAChRs are gated by synaptic release of acetylcho-
line, have four transmembrane domains and multimerize to
form functional pentamers.
It is unclear which structural features SSS recognizes on
each class of membrane protein, especially in the case of
Sh, which is thought to expose little surface area outside
the plasma membrane. X-ray structures of a-cobtratoxin
(a-Cbtx) bound to Lymnaea stagnalis acetylcholine binding
protein (LS-AChBP) show interactions between two loops of
a-Cbtx and both the agonist binding pocket and the cis
loop of AChBP [30]. Using this information and a nuclear
magnetic resonance structure of water-soluble lynx1, Lyuk-
manova et al. modeled a possible interaction of lynx1 with
the same site, although the loops of lynx1 were shorter than
those of a-Cbtx and did not form as many contacts with the
AChBP [31].
It is also unclear whether such interactions, even if trans-
lated to SSS, would result in acute and direct antagonism of
nAChR activity or, alternatively, reduction in targeting of
receptors at the cell surface. Both potential mechanisms
of action could account for the reduced a4/b2 activity we
observed in cells transfected with qvr/sss. In addition, it is
unknown whether a single SSS molecule can interact with
both Sh and nAChRs simultaneously. However, our data sug-
gest that all three proteins are coexpressed in some regions of
the brain, particularly the mushroom bodies, which we and
others have shown to play an important role in controlling
sleep [27, 28, 32]. We previously showed that SSS is enriched
in these structures, as well as in the antennal nerves, the
superior protocerebrum, and the lobula plate of the optic
lobes [7], and here we show that MB-Gal80 reduces the ability
of sss-Gal4>UAS-sss to restore sleep to sssP1 mutants. None-
theless, the contribution of the MBs relative to other brain loci
in regulating sleep via SSS, Sh, and Da3 still needs to be
determined.
A particularly intriguing feature of SSS is its ability to reduce
both membrane excitability and synaptic transmission, which
endows the protein with unusual gain control over neuronal
activity. In the present context, we propose that SSS reduces
the activity of wake-promoting neurons through two pathways
to permit sleep (Figure 6). In one, it enhances ShK channel pro-
tein levels and open channel probability to reduce neuronal
excitability. In another pathway, it inhibits nAChR signaling
to reduce synaptic transmission. In qvr/sss mutants the pro-
cesses are reversed in wake-promoting neurons: K channel
activity is reduced, leading to increased excitability, and
nAChR activity is increased, leading to increased synaptic
transmission. In these as well as Sh mutants, reduction
of nAChR expression by RNAi knockdown or of nAChR activity
by pharmacological antagonism reduces the activity of wake-
promoting neurons within a range in which sleep can once
again occur (Figure 6).
Figure 5. The Molecular Function of Mammalian
qvr/sss Homologs Is Conserved
(A) Myc-tagged lynx1 coimmunoprecipitates with
HA-tagged Da3 in lysates from transiently trans-
fected Cos-7 cells (lane 2) but not in the absence
of Da3 (lane 1).
(B) Lynx1 also coimmunoprecipitates with GFP-
tagged Kv1.2 (lane 3) and Sh (lane 7). Lynx1
does not coimmunoprecipitate with the GFP-
tagged transmembrane protein Grid2 (lane 5).
(C) Expression of UAS-lynx1 under the control of
sss-Gal4 partially restores sleep to sssP1 mutants
(n > 18 for each group). ***p < 0.001 by one-way
ANOVA with Bonferroni post test. Error bars
indicate the SEM.
See also Figure S2.
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627Our finding that the molecular properties of SSS are shared
by the mammalian homolog lynx1 suggests that ly6 proteins in
general may have evolved a multitude of roles in regulating
basic properties of the nervous system. It is notable that
fundamental plastic processes are perturbed in loss-of-
function mutants of qvr/sss and lynx1. For example, in sssP2
hypomorphs sleep homeostasis is impaired [6], and in lynx1
knockouts the critical period for ocular dominance plasticity
is extended to adulthood [17]. Although phenotypes have
been described for additional ly6 mutants in both flies and
mice, only in the case of SSS, lynx1 and lynx2 have molecular
effectors been identified in vivo, and these are either K chan-
nels or nAChRs. Since over 20 ly6 genes have been described
in Drosophila [14] and there appear to be many homologous
genes in mammals, additional roles for these molecules may
remain to be discovered.
In summary, we have identified a role for SSS in regulating
synaptic transmission, inaddition to itsestablished role in regu-
lating membrane excitability. Both functions appear to be
important for the ability of SSS to regulate sleep in Drosophila.
The ability of lynx1 to substitute for SSS and to formcomplexes
with effectors of SSS, namely Sh-type K channels and nAChRs,
suggests that lynx1 and perhaps othermammalian ly6 proteins
possess similar, multifunctional roles in controlling neuronal
activity. Potassium channels, nAChRs, and their modulators
are key regulators or targets for molecular intervention in
various human disorders, including ataxias, congenital deaf-
ness, epilepsy, cardiac arrhythmias, type II diabetes, autoim-
mune diseases such as multiple sclerosis and rheumatoid
arthritis, cognitive decline in Alzheimer’s disease, loss ofmotor
coordination in Parkinson’s disease, nicotine addiction and its
associated risk of developing cancer, and cardiovascular dis-
ease from smoking [33–39]. Understanding the functions of
ly6 proteins may provide insights into these disorders as well
as new screening strategies for more selective and efficacious
pharmacotherapeutic regulators of neuronal function.Experimental Procedures
Fly Stocks and Transgenic Fly Lines
sssP1, sss-Gal4, and UAS-sss flies were described previously [6, 7]. Other
lines were provided as follows: Shmns (Chiara Cirelli), UAS-shits (Toshi Kita-
moto), and UAS-TRPA1 (Paul Garrity). UAS-Da3 (stock d03389) was from
the Exelixis collection at Harvard. Other fly lines were obtained from the
Bloomington Stock Center (UAS-dicer [24650], UAS-tdTomato [32221],
and UAS-nAChR RNAis [28688, 27493, 27671, 31985, 25943, 25835,
27251, 31883, 28038, and 25927]). UAS-lynx1 flies were generated by target-
ing of UAS-lynx1 in pUAST-attB to the attP site of y1,w67c23;;attP2 flies
(Rainbow Transgenics) and outcrossing of transgenic animals into a w1118
iso31 background for two generations.Behavior Assays
One- to five-day-old flies were loaded into glass tubes containing 5%
sucrose and 2% agarose and entrained to a 12 hr:12 hr light:dark (LD) cycle
for 2 days beforemeasurement of sleep/wake patterns using theDrosophila
Activity Monitoring System (Trikinetics). Sleep was defined as 5 min of inac-
tivity and was measured as previously described [22]. Experiments were
carried out at 25C except those involving 6 hr heat pulses to 27C to acti-
vate TRPA1 or to 28C to activate shits, in which case baseline temperature
was maintained at 22C.
Prior to drug treatment, sucrose/agarose mixtures were equilibrated to
50C, and the appropriate amounts of concentrated 4-AP (pH adjusted to
7.0; Acros Organics) or mecamylamine (R&D, Tocris) were added. Animals
that had been entrained for 2 days on sucrose/agarose alone were switched
to activity tubes containing the drug mixture at ZT0, and sleep was
measured beginning 1 day later for a period of 24 hr. Animals that diedwithin
4 days of drug intake were excluded from analysis.
Quantitative PCR
For each sample, 30–50 brains or 7–12 heads from 5- to 9-day-old flies
were lysed in Trizol (Life Technologies), and first-strand cDNA was synthe-
sized from extracted RNA using High Capacity cDNA Reverse Transcription
(ABI). qPCR was performed on each cDNA sample using the primers listed
in the Table S1, and results were normalized to levels measured for
RP49. Relative expression was further normalized to brain Da1 levels (Fig-
ure S4A) or levels of Da3 or Db3 transcript measured in w1118 controls (Fig-
ure 3). All primer pairs were validated for amplification efficiencies (R2)
greater than 0.98.
Molecular Biology
For generation of GFP-tagged Shaker, eGFP was amplified from eGFP-
C3 (Clontech) by PCR using Hind-eGFP-F and eGFP-Xho-R primers (Table
S2) and subcloned in frame at the 50 end of ShD in pcDNA3 [7] using
HindIII and XhoI. GFP-tagged Kv1.2 was generated by replacement of
ShD with Kv1.2 that had been amplified by PCR with Xho-Kcna2-F and
Kcna2-Not-R2 primers (Table S2) and cut with XhoI-NotI. GFP-GRID2
was similarly generated by amplification of eGFP with EcoR1-eGFP-F
and eGFP-Kpn1-R primers (Table S2) and subcloning of the fragment
into the EcoRI and KpnI sites of Flag-GRID2 (a kind gift from Z. Yue,
Mt. Sinai).
For generation of Myc-tagged SSS, EcoRV and Xho1 sites were first in-
serted into sss in pcDNA3 [7] by PCR using SSS-Cmyc-S and SSS-Cmyc-
AS primers (Table S2). Cmyc-S and Cmyc-AS oligos encoding the Myc
epitope (Table S2) were then annealed and subcloned into the newly engi-
neered EcoRV and Xho1 sites. For generation of Myc-tagged lynx1, an
EST (I.M.A.G.E. ID 5325123, Open Biosystems) encoding full-length mouse
lynx1 was first amplified by PCR with primers EcoR1-Lynx1-F and Lynx1-
Not1-R (Table S2) and subcloned between the EcoRI and NotI sites of
pcDNA3. A fragment of Myc-tagged SSS was then amplified by PCR with
the primers Lynx1-Myc-F and Lynx1-Myc-R (Table S2), and the resulting
product was used for primer extension using lynx1 in pcDNA3 as a template.
The product of this reaction was then amplified with EcoR1-Lynx1-F and
Lynx1-Not1-R primers (Table S2) and subcloned between the EcoR1 and
Not1 sites of pcDNA3.
To generate HA-tagged Da3, we first subcloned oligos Not1-HA-Xba1-S
and Not1-HA-Xba1-AS (Table S2) between the NotI and XbaI sites of
pcDNA3 to make pcDNA3-HA. For fusion of Da3 to the HA epitope, Da3
was amplified by PCR from an EST (DGRC clone number 12624) using
Figure 6. Model for Control of Sleep by SSS in Wake-Promoting Neurons
SSS reduces neuronal activity in arousal-promoting neurons through two
pathways to permit sleep. SSS enhances Sh K channel activity to reduce
intrinsic excitability (left). SSS also suppresses nAChR activity to reduce
synaptic transmission (right). Pharmacological or genetic antagonism of
nAChR activity functionally substitutes for SSS to restore sleep to sssP1
mutants (right). The bidirectional arrow (left) reflects mutual dependence
of Sh and SSS for elevated expression levels of both proteins.
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628primers Da3-Kpn1-F and Da3-Not-R (Table S2) and subcloned into the KpnI
and NotI sites of pcDNA3-HA.
UAS-lynx1 was generated by subcloning of the previously described full-
length mouse EST into pUAST-attB between the EcoRI and NotI sites.
Immunohistochemistry
Three- to seven-day-old female brains were dissected in ice-cold PBS
before fixation in 4% paraformaldehyde. Brains were blocked in PBST
(PBS and 0.3% Triton X-100) containing 5% normal donkey serum (Jackson
Laboratory) and 5% normal goat serum (Life Technologies). Brains were
incubated with 1:200 rat anti-Sh [40] precleared with ShDf lysate followed
sequentially by incubation with 1:250 rabbit anti-Da3 bleed 88 [26].
Brains were washed with PBST and stained with 1:1000 Alexa 633 anti-
rabbit (Life Technologies) and 1:1,000 anti-rat Alexa 488 (Jackson
ImmunoResearch). After additional washes, brains were equilibrated and
mounted in Vectashield (Vector Labs). Images were taken at 403magnifica-
tion on a Leica SP5 confocal microscope using 0.5 mmstack intervals. Z pro-
jection images (5 mm) were generated and rotated, and brightness/contrast
adjustments were made across the entirety of the images using Fiji [41].
Cell Culture and Coimmunoprecipitations
Cos-7 and HEK-tsa cells were maintained at 25C and 7.5% CO2 in culture
medium consisting of 10% fetal bovine serum (Omega), 1% penicillin/
streptomycin (Mediatech), and 1% L-glutamine (Sigma) in low-glucose
Dulbecco’s modified Eagle’s medium with 2 mM L-Glutamine (Mediatech).
Cells were grown to 50%–80% confluence for transfection with X-treme-
gene HP reagent (Roche) at a 2:1 ratio of transfection reagent to DNA in
Optimem (Life Technologies). Transfection mixture was removed 24 hr after
transfection and replaced with normal growth medium. Cells were lysed
48 hr after transfection in SDS lysis/immunoprecipitation (IP) buffer
(10 mM Tris [pH 7.5], 100 mM NaCl, 5mM EDTA, 1% Triton X-100, and
0.05% SDS) with complete protease inhibitors (Roche). For coimmunopre-
cipitation assays, 500 mg of total cell lysate was incubated in a total volume
of 1 ml SDS lysis/IP buffer with primary antibodies overnight at 4C on a
rotating platform. The following day, protein-G-conjugated magnetic beads
(NEB) were added and incubated at 4C for 2–5 hr. Beads were washed
three times in a 1 ml volume of IP wash buffer (10 mM Tris [pH 7.5],
100 mM NaCl, 5 mM EDTA, 0.5% Triton X-100, and 0.05% SDS) and resus-
pended in 23 LDS sample buffer (Life Technologies). Antibodies used were
rabbit anti-GFP (Life Technologies) or rabbit anti-HA (Rockland).
Western Blot Analyses
Western blot analyses of Cos-7 cell lysates and coimmunoprecipitation
complexes were performed as previously described [40]. For 20% input
conditions, 100 mg of protein was loaded per lane. Proteins were detected
using the following antibodies: rabbit anti-GFP (Life Technologies), mouse
anti-HA (Covance), mouse anti-Myc (Santa Cruz Biotechnologies), and
mouse anti-actin (Millipore EMD).
FRET-Based Measurements of nAChR Activity
Measurements of a4b2 nAChR activity were performed as previously
described [29] with the following alterations: HEK-tsa cells were transiently
transfected with a4-pciNeo and b2-dm-pciNeo (gifts from H. Lester) plus
TN-XXL (gift from P. Taylor) supplemented with either sss-pcDNA3 orpcDNA3 alone at a ratio of 1:1:2:10, respectively. Cells were preincubated
in growth media containing 1 mM nicotine (R&D, Tocris) for 20 hr prior to
assay in artificial cerebral spinal fluid (ACSF; 121 mM NaCl, 5 mM KCl,
26 mM NaHCO3, 1.2 mM NaH2PO4H2O, 10 mM Glucose, 5 mM HEPES,
2.4 mM Ca2+, and 1.3 mM Mg2+ [pH 7.4]). Maximum responses were calcu-
lated from concentration-response curves averaged over four experiments,
each performed in triplicate, with results normalized to the maximum
response of a4b2 nAChR without sss. One-way ANOVA repeated-measures
analysis with Dunnett’s multiple comparison post test was used for statisti-
cal analysis.
Supplemental Information
Supplemental Information includes Supplemental Experimental Proce-
dures, five figures, and two tables and can be found with this article online
at http://dx.doi.org/10.1016/j.cub.2014.02.026.
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